Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: August 14, 2022

Details for Patent: 7,855,190

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 7,855,190
Title:Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
Abstract:The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
Inventor(s): Bell; Robert G. (Palm Harbor, FL), Ben-Maimon; Carole S. (Merion, PA), Iskold; Beata (Livingston, NJ), Bronnenkant; Lance J. (Snyder, NY), Hait; Howard (Wilmington, DE), Reape; Kathleen Z. (Bryn Mawr, PA)
Assignee: Teva Women's Health, Inc. (Woodcliff Lake, NJ)
Application Number:10/892,404
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,855,190
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 7,855,190

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Teva Branded Pharm LOSEASONIQUE ethinyl estradiol; levonorgestrel TABLET;ORAL 022262-001 Oct 24, 2008 AB RX No No See Plans and Pricing See Plans and Pricing PREVENTION OF PREGNANCY See Plans and Pricing
Teva Branded Pharm SEASONIQUE ethinyl estradiol; levonorgestrel TABLET;ORAL 021840-001 May 25, 2006 AB RX Yes Yes See Plans and Pricing See Plans and Pricing PREVENTION OF PREGNANCY See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,855,190

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004257772 See Plans and Pricing
Australia 2010201022 See Plans and Pricing
Brazil PI0412493 See Plans and Pricing
Canada 2524474 See Plans and Pricing
Canada 2532089 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.